Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luke A Jelen

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 26, 2022
New antidepressants: New day or false dawn?Luke A Jelen, Allan H Young
International Review of Psychiatry (Abingdon, England)|February 11, 2021
Ketamine for depressionLuke A Jelen, James M Stone
Therapeutic Advances in Psychopharmacology|March 2, 2018
Alternatives to ketamine in depression: state-of-the-art and future perspectivesLuke A Jelen, Sinead King, James M Stone
Bjpsych Open|May 10, 2024
Guidelines for ketamine use in clinical psychiatry practiceLuke A Jelen, Rupert McShane, Allan H Young
Current Topics in Behavioral Neurosciences|November 4, 2023
Opioid Mechanisms and the Treatment of DepressionLuke A Jelen, Allan H Young, Mitul A Mehta
Journal of Psychopharmacology (Oxford, England)|November 6, 2020
Ketamine: A tale of two enantiomersLuke A Jelen, Allan H Young, James M Stone
Journal of Psychopharmacology (Oxford, England)|January 26, 2018
Beyond static measures: A review of functional magnetic resonance spectroscopy and its potential to investigate dynamic glutamatergic abnormalities in schizophreniaLuke A Jelen, Sinead King, Paul G Mullins, et al.
Neuroscience and Biobehavioral Reviews|May 13, 2021
The anterior cingulate cortex as a key locus of ketamine's antidepressant actionLaith Alexander, Luke A Jelen, Mitul A Mehta, et al.
Current Topics in Behavioral Neurosciences|February 6, 2021
New Pharmacological Interventions in Bipolar DisorderMario F Juruena, Luke A Jelen, Allan H Young, et al.
Neuroscience and Biobehavioral Reviews|August 1, 2022
The opioid system in depressionLuke A Jelen, James M Stone, Allan H Young, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 26, 2022
New antidepressants: New day or false dawn?Luke A Jelen, Allan H Young
International Review of Psychiatry (Abingdon, England)|February 11, 2021
Ketamine for depressionLuke A Jelen, James M Stone
Therapeutic Advances in Psychopharmacology|March 2, 2018
Alternatives to ketamine in depression: state-of-the-art and future perspectivesLuke A Jelen, Sinead King, James M Stone
Bjpsych Open|May 10, 2024
Guidelines for ketamine use in clinical psychiatry practiceLuke A Jelen, Rupert McShane, Allan H Young
Current Topics in Behavioral Neurosciences|November 4, 2023
Opioid Mechanisms and the Treatment of DepressionLuke A Jelen, Allan H Young, Mitul A Mehta
Journal of Psychopharmacology (Oxford, England)|November 6, 2020
Ketamine: A tale of two enantiomersLuke A Jelen, Allan H Young, James M Stone
Journal of Psychopharmacology (Oxford, England)|January 26, 2018
Beyond static measures: A review of functional magnetic resonance spectroscopy and its potential to investigate dynamic glutamatergic abnormalities in schizophreniaLuke A Jelen, Sinead King, Paul G Mullins, et al.
Neuroscience and Biobehavioral Reviews|May 13, 2021
The anterior cingulate cortex as a key locus of ketamine's antidepressant actionLaith Alexander, Luke A Jelen, Mitul A Mehta, et al.
Current Topics in Behavioral Neurosciences|February 6, 2021
New Pharmacological Interventions in Bipolar DisorderMario F Juruena, Luke A Jelen, Allan H Young, et al.
Neuroscience and Biobehavioral Reviews|August 1, 2022
The opioid system in depressionLuke A Jelen, James M Stone, Allan H Young, et al.
Pageof 3